Effect of Sariva (Decalepis hemiltonii-an ayurvedic drug) in the improvement of the quality of blood

Comparative Study of Vidhishoniteeya Adhyaya of Charaka Samhita & Shonitavarnaneeya Adhyaya of Sushruta Samhita w.s.r. to Raktasarata & Raktaprasadana.

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2013/10/004073

Enrollment

Registered

2013-10-17

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Sariva Ghanavati Tablet: Group A received Sariva Ghanavati tablet 4 tablets of 500 mg each orally on empty stomach twice a day for 28 days Control Intervention1: Trial Group (with Lif

Eligibility

Inclusion criteria

Inclusion criteria: Healthy volunteers between 20-40 yrs age group will be selected from the surrounding area of research place without any bar of race, religion and sex.

Exclusion criteria

Exclusion criteria: Volunteers younger than 20 years and older than 40 years age. Patients suffering from any other systemic disease. Patient having any established pathology of mahasrotas.

Design outcomes

Primary

Measure	Time frame
Sariva Ghanvati is therapeutically beneficial in the condition of slightly vitiated blood.Timepoint: 1 month	—

Secondary

Measure	Time frame
Improvement in quality of blood(Raktasarata)Timepoint: after 1 month	—

Countries

India

Contacts

Public ContactDr Mahesh Vyas

Institute for Post Graduate Teaching and Research in Ayurveda

dwivedirb53@rediffmail.com09426206906

Outcome results